Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  1. 4 Open-market sale Executive VP Global Operations sold 3,144 shares at $12.24 ($38,488)
  2. 4 Open-market sale EVP Global Marketing&Portfolio sold 5,669 shares at $12.27 ($69,559)
  3. 4 Open-market sale Exec. VP, European Commercial sold 6,199 shares at $12.24 ($75,886)
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. 4 Open-market sale Executive VP, Global R&D sold 2,459 shares at $9.92 ($24,396)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Executive VP, Global R&D sold 4,310 shares at $10.49 ($45,214)
  9. 8-K Event Material agreement · New debt or obligation
  10. 10-Q Report Quarterly Report
  11. 8-K Event Executive or director change
  12. 8-K Event Results of operations
  13. 4 Open-market sale EVP, Chief Financial Officer sold 242 shares at $8.83 ($2,138)
  14. 4 Option exercise President and CEO acquired 63,613 shares (option exercise)
  15. 8-K Event Regulation FD disclosure
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Executive or director change
  18. 4 Open-market sale EVP, North America Commercial sold 494 shares at $7.83 ($3,869)
  19. 4 Open-market sale EVP, Growth Markets Commercial sold 962 shares at $7.82 ($7,523)
  20. 4 Open-market sale EVP, Chief Financial Officer sold 1,406 shares at $7.83 ($11,011)

Page 39 of 128 · 2,555 filings